Fennec Pharmaceuticals Inc. Common Stock (FENC) is a publicly traded Healthcare sector company. As of November 6, 2026, FENC trades at $9.39 with a market cap of $362.95M and a P/E ratio of -92.86. FENC moved -9.66% today. Year to date, FENC is +24.87%; over the trailing twelve months it is +13.52%. Its 52-week range spans $4.68 to $13.25. Analyst consensus is strong buy with an average price target of $17.60. Rallies surfaces FENC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest FENC news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $9.39 |
| Market Cap | $362.95M |
| P/E Ratio | -92.86 |
| EPS | $-0.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.25 |
| 52-Week Low | $4.68 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $59.22M |
| Net Income | $-3.25M |
| Gross Margin | 0.00% |
5 analysts cover FENC: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $17.60.